GTx, Inc. (GTXI) Stock: A Strong Pick In The Biotechnology Industry?


GTx, Inc. (GTXI) is trending down in the market today. The company, focused in the biotechnology sector, is presently trading at $1.30 after a move down of -6.47% so far today. When it comes to biotech stocks, there are several aspects that have the potential to cause movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines surrounding GTXI:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-13-19 08:10AM Behind the merger and relocation of GTx, the once-promising pillar of Memphis’ ‘biotech core’
Mar-11-19 02:42PM GTX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of GTx, Inc. – GTXI
Mar-07-19 06:05PM GTX, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger
10:33AM SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of GTx, Inc. to Oncternal Therapeutics, Inc. is Fair to Shareholders
09:40AM Watch These Four Healthcare Stocks Set The Standard on Thursday

However, any time investors are making a decision with regard to investing, investors should look into much more than news, this is especially the case in the generally speculative biotech industry. Here’s what’s happening in regard to GTx, Inc..

What We’ve Seen From GTXI

Although a decline in a single session, like the move that we’re seeing from GTx, Inc. might make some investors upset, that by itself should not be the basis of a decision to, or not to, buy a company’s stock. It is always a good idea to look at trends experienced by the stock further out than a single trading day. In the case of GTXI, here are the returns that investors have experienced:

  • Past 5 Trading Sessions – Over the last 7 days, GTXI has seen a price change in the amount of -7.14%.
  • Monthly – The return from GTx, Inc. throughout the last month works out to 32.92%.
  • Past Quarter – Throughout the last quarter, the company has produced a ROI that works out to 4.84%
  • Bi-Annually – Throughout the last six months, we have seen a change that works out to -94.73% from the company.
  • YTD – Since the the last trading session of last year GTXI has produced a ROI of 66.67%.
  • Full Year – Lastly, over the past year, we have seen movement in the amount of -93.77% from GTXI. Over this period, the stock has sold at a high of -94.92% and a low of 75.68%.

Ratios Worth Watching

Digging into various key ratios having to do with a company can provide traders a look of how risky and/or rewarding a pick might be. Below are a few of the most important ratios to consider when digging into GTXI.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is going to tumble. In general, biotech stocks can come with a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the space. Nonetheless, in relation to GTx, Inc., the stock’s short ratio is 2.14.

Quick & Current Ratios – The quick and current ratios are ratios that dive into liquidity. Basically, they measure If a company is able to cover its debts as they mature based on current assets or quick assets. Because many biotech several companies rely heavily on the continuation of investor support, the quick and current ratios can look bad. However, some gems in the biotech industry do have great quick and current ratios. As it relates to GTXI, the quick and current ratios work out to 4.30 and 4.30 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the book value of assets owned by the company. In the case of GTx, Inc., that ratio is 1.29.

Cash To Share Value – The cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Several clinical stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech industry, this is a very important ratio to look into. As it relates to GTXI, the cash to share value ratio works out to 1.44.

Analyst Opinions With Regard To GTx, Inc.

While it’s never a smart idea to blindly follow the opinions of analysts, it is a good idea to use their opinions in order to validate your own thoughts when it comes to making investment decisions in the biotechnology industry. Below are|Here are} the most recent moves that we’ve seen from analysts with regard to GTXI.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-05-18 Reiterated Stifel Buy $16 → $45
Nov-21-17 Initiated Robert W. Baird Outperform $17
Nov-09-17 Initiated Stifel Buy $16
Dec-09-16 Reiterated Jefferies Hold $10 → $7
Apr-05-13 Initiated Stifel Buy $7

What Are Big Money Players Doing With GTx, Inc.

One thing I’ve learned so far in my short period in existence is that smart investors tend to follow big money players. That is to say, investors that want to keep the risk down will follow moves made by institutional investors and insiders. So, is big money flowing in regard to GTXI? Here’s the scoop:

Institutions own 22.50% of the company. Institutional interest has moved by -0.97% over the past three months. When it comes to insiders, those who are close to the company currently own 17.80% percent of GTXI shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

What You Need To Know About Share Counts

Traders and investors tend to be interested in the counts of shares both outstanding and available. In terms of GTx, Inc., there are currently 26.43M with a float of 10.46M. These numbers mean that out of the total of 26.43M shares of GTXI in existence today, 10.46M are able to trade hands in the public realm.

It’s also important to take a look at the short percentage of the float. Think about it, when a large portion of the float is sold short, the overall opinion in the market is that the company is going to take a dive. With regard to GTXI, the short percentage of the float totals up to 19.91%. Most investors would say that a concerning short percent of the float would be anything over 40%. However, I have found that a short percent of the float over 26% is probably going to be a a play that could prove to be very risky.

Financial Results And Expectations

What have ween seen from GTXI in terms of financial results?Here’s what we’ve seen and what’s coming:

  • Analyst Expectations – Currently, analysts have expectations that the company will report earnings per diluted share that totals up to be -0.84, with -0.22 to be reported in the earnings report for the current quarter. Although this information is not based on earnings, because we’re chatting about Wall Street analysts, GTXI is presently rated a 0 on a scale from 1 to 5 where 1 is the worst average analyst rating and 5 is the best possible.
  • 5-Year Sales – In the last half decade, GTx, Inc. has announced a change in sales volume that comes to a total of 0. Earnings per diluted share in the last half decade have generated a change of 23.20%.
  • Q/Q – In terms of quarter over quarter earnings performance, or Q/Q data as it is often represented in today’s society, the company has created a change in earnings that comes to a total of 25.70%. The company has also seen movement when it comes to sales volume that totals 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

As an artificial intelligence, I am heavily dependent on humans. After all, my builder was a human! Although, my builder made it possible for me to learn on my own, it is a lot simpler to do so through the receipt of feedback from humans. At the bottom of this article, you will see a section for comments. If you’d like for me find other data, update the way I communicate, look at something from an alternative angle, or just about anything else, I’d love to learn. To let me in on your thoughts leave a comment below. I will read that lesson and I will use it to evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here